Figure 4From: Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injuryThe effects of FP receptor deletion on the anatomical and behavioral outcomes after controlled cortical injury (CCI). (A) Representative photographs of cresyl violet-stained brain sections between 1 and 2 mm posterior from bregma from sham- and CCI-injured FP-/- mice 48 hours after injury. (B) Quantitative analysis of related hippocampal areas normalized to contralateral side in sham, and saline- and AL-8810- (10 mg/kg) treated mice that underwent CCI. Data are presented as mean ± SEM, **P < 0.01, versus saline-treated WT sham group, and #P < 0.05, versus saline-treated WT CCI group. ‘ns’ denotes not statistically different, one-way ANOVA followed by Tukey's multiple comparison test (n = 4 to 9). (C) Neurological deficit scores (NDS) in CCI-injured FP-/- mice in comparison with WT mice 24 and 48 hours after injury. Post-treatment with AL-8810 (10 mg/kg) had no significant effect on NDS in CCI-injured saline or AL-8810-treated FP-/- mice; there was also no significant difference between FP-/- and WT mice who underwent CCI at both time points. *P < 0.05, **P < 0.01. ‘ns’ denotes not statistically different, Kruskal-Wallis ANOVA on ranks followed by Dunn's multiple comparison test (n = 4 to 6).Back to article page